Saitz Richard
Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, 91 E Concord Street, Boston, MA 02118-2644, USA.
Subst Abus. 2007;28(3):3-6. doi: 10.1300/J465v28n03_02.
About 40 years since the first controlled study, screening and brief intervention (SBI) are being disseminated into practice. But many unanswered questions remain. Studies in this special issue address what we know and don't know about alcohol and drug SBI, cost-effectiveness, patient preferences, education for clinicians, quality performance measures, 'no-contact' SBI, predictors of behavior change, and methodological concerns with the SBI literature. The best evidence for efficacy of SBI is that it can lead to decreased consumption in primary care patients with non-dependent unhealthy alcohol use. But further research is needed on brief drug screening tools, efficacy of SBI for drugs, effectiveness in real world settings, integration of SBI for alcohol and drugs with other health behaviors, effects of SBI on alcohol and drug consequences, effects on dependence among those not seeking help, and on how to best disseminate the efficacious elements of SBI into practice.
自首次对照研究开展约40年来，筛查与简短干预（SBI）正逐渐应用于实际。但仍存在许多未解答的问题。本期特刊中的研究探讨了我们对于酒精和药物SBI、成本效益、患者偏好、临床医生教育、质量绩效指标、“无接触”SBI、行为改变预测因素以及SBI文献的方法学问题所了解和未知的内容。SBI疗效的最佳证据是，它可使非依赖性不健康饮酒的初级保健患者饮酒量减少。但对于简短药物筛查工具、SBI对药物的疗效、在现实环境中的有效性、酒精和药物SBI与其他健康行为的整合、SBI对酒精和药物后果的影响、对未寻求帮助者成瘾的影响以及如何将SBI的有效要素最佳地应用于实际等方面，仍需进一步研究。
